MAP2K1 and osteomyelitis: We investigated the role of MEK1 signaling in modulating S. aureus-induced osteomyelitis pathogenesis by establishing a murine femoral infection model through S. aureus inoculation and subsequently treated the animals with combination therapy comprising GDC-0973 (a selective MEK1 inhibitor) and gentamicin.